ArticleScientific reports2025
Subjective distress mediates the association between olfactory dysfunction duration and depression in post COVID 19 patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prevalence of alpha-synuclein seeding activity in the Olfactory Mucosa following SARS-CoV-2 infection: results from a pilot study.Acta neuropathologica · 2026Observational
- Emotional Burden of Olfactory Dysfunction: A Psychological Cluster Analysis from a Tertiary Smell and Taste Clinic.International forum of allergy & rhinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Olfactory dysfunction (OD) has been reported in individuals who recovered from COVID-19. Those with OD after COVID-19 (COVID-19 group) exhibited more severe psychiatric symptoms than those with OD from other etiologies (non-COVID-19 group). This study investigates differences in psychological symptoms and related clinical factors between these groups. Fifty-two participants (COVID-19 group: 26; non-COVID-19 group: 26) were recruited. Both objective and subjective olfactory function were assessed, and symptoms of depression, anxiety, and perceived stress were measured using self-reported scales. There were no significant differences in objective and subjective olfactory function or psychological symptoms between the groups, except for age and the short version of the Questionnaire of Olfactory Disorders-negative statements (sQOD-NS). The sQOD-NS score was negatively correlated with OD duration only in the COVID-19 group. In both groups, the sQOD-NS was significantly correlated with Patient Health Questionnaire-9 (PHQ-9) scores. Mediation analysis showed that OD duration indirectly affected PHQ-9 scores via the sQOD-NS in the entire sample, particularly in the COVID-19 group. These findings suggest that subjective distress from OD may mediate the relationship between OD duration and depressive symptoms in COVID-19 patients, highlighting the need for targeted psychiatric interventions after recovery from COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.